Here are four things to know:
1. Net loss for AHN was $13 million in the third quarter of 2024, down from a net loss of $66.8 million in the third quarter of 2023.
2. Total revenue for the system was $1.3 billion in the third quarter, an 8% increase from $1.2 billion during the same period in 2023. Expenses were $1.3 billion in the third quarter, up from $1.2 billion during the same quarter in 2023.
3. Days of cash on hand for the system was 51 on Sept. 30, 2024, and AHN has a long-term debt of $884.7 million.
4. AHN is part of Highmark Health, which saw an operating income of $273 million and net income of $529 million in the first nine months of 2024, according to a Nov. 26 Highmark news release. Highmark Health Plans saw an operating income of $275 million through Sept. 30, 2024 and $16.6 billion in operating revenue.
“The health insurance organization faced headwinds from rising health care usage, continued effects of Medicaid redeterminations, and high prescription drug costs, particularly GLP-1s,” the release said.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
